1 – 10 of 27
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2025
-
Mark
An optimised Bcl-3 inhibitor for melanoma treatment
- Contribution to journal › Article
- 2024
-
Mark
Discovery of a small molecule that inhibits Bcl-3-mediated cyclin D1 expression in melanoma cells
- Contribution to journal › Article
- 2018
-
Mark
Genetic variation of acquired structural chromosomal aberrations
- Contribution to journal › Article
- 2017
-
Mark
Statins, HMGCR and Breast Cancer
(2017)
- Thesis › Doctoral thesis (compilation)
-
Mark
High expression of cyclin D1 is associated to high proliferation rate and increased risk of mortality in women with ER-positive but not in ER-negative breast cancers
- Contribution to journal › Article
- 2015
-
Mark
The impact of Bcl-3 expression and signaling in cancer
- Thesis › Doctoral thesis (compilation)
- 2014
-
Mark
Associations of sex, anthropometric and reproductive factors with clinicopathological and molecular characteristics of colorectal cancer
- Thesis › Doctoral thesis (compilation)
-
Mark
Associations of hormone replacement therapy and oral contraceptives with risk of colorectal cancer defined by clinicopathological factors, beta-catenin alterations, expression of cyclin D1, p53, and microsatellite-instability
- Contribution to journal › Article
- 2013
-
Mark
A cohort study of sex differences and prognostic biomarkers in colorectal cancer
- Thesis › Doctoral thesis (compilation)
-
Mark
Associations of beta-catenin alterations and MSI screening status with expression of key cell cycle regulating proteins and survival from colorectal cancer
- Contribution to journal › Article
